For its first fiscal quarter (ending March 31), Exelixis Inc (NASDAQ: EXEL) has reported a 0% change in E.P.S. from $0.12 a year ago to $0.12 in the current quarter. Relative to the consensus estimate of $0.39, this was a shortfall of $-0.27. E.P.S. were $0.65 for the latest four quarters through March 31 versus $0.48 for the same period a year ago — an increase of 35%.
Recent Price Action
On 4/30/24, Exelixis Inc (NASDAQ: EXEL) stock declined modestly by -1.1%, closing at $23.46. This decline was accompanied by normal trading volume. The stock has performed in line with the market over the last nine months and has risen 2.6% during the last week.
Current PriceTarget Research Rating
With future capital returns forecasted to be above the cost of capital, EXEL is expected to continue to be a major Value Builder.
Exelixis has a current Value Trend Rating of C (Neutral). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing consistent signals. Exelixis has a neutral Appreciation Score of 44 and a slightly positive Power Rating of 60, producing the Neutral Value Trend Rating.
Rating Review
In light of this new information we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment